{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:48:03Z","timestamp":1780584483519,"version":"3.54.1"},"reference-count":24,"publisher":"Baskent University","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.6002\/ect.2018.0095","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T01:47:46Z","timestamp":1549417666000},"page":"52-58","source":"Crossref","is-referenced-by-count":11,"title":["Successful Treatment With Direct-Acting Antiviral Agents of Hepatitis C in Patients With End-Stage Renal Disease and Kidney Transplant Recipients"],"prefix":"10.6002","volume":"17","author":[{"name":"the Department of Gastroenterology, Baskent University Faculty of Medicine, Ankara, Turkey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di\u011fdem","family":"\u00d6zer Etik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuretdin","family":"Suna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan","family":"\u00d6cal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haldun","family":"Sel\u00e7uk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00dclk\u00fc","family":"Da\u011fl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turan","family":"\u00c7olak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Hilmio\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Sedat","family":"Boyac\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Haberal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4021","reference":[{"issue":"5","key":"ref0","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1159\/000355615","article-title":"Hepatitis C infection is very rarely treated among hemodialysis patients","volume":"38","author":"Goodkin","year":"2013","unstructured":"1.\tGoodkin DA, Bieber B, Gillespie B, Robinson BM, Jadoul M. Hepatitis C infection is very rarely treated among hemodialysis patients. Am J Nephrol. 2013;38(5):405-412.","journal-title":"Am J Nephrol"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"593291","DOI":"10.4061\/2011\/593291","article-title":"Hepatitis C and kidney transplantation","volume":"2011","author":"Carbone","year":"2011","unstructured":"2.\tCarbone M, Cockwell P, Neuberger J. Hepatitis C and kidney transplantation. Int J Nephrol. 2011;2011:593291.","journal-title":"Int J Nephrol"},{"issue":"9","key":"ref2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/tri.12360","article-title":"Hepatitis C virus infection in end-stage renal disease and kidney transplantation","volume":"27","author":"Burra","year":"2014","unstructured":"3.\tBurra P, Rodriguez-Castro KI, Marchini F, et al. Hepatitis C virus infection in end-stage renal disease and kidney transplantation. Transpl Int. 2014;27(9):877-891.","journal-title":"Transpl Int"},{"issue":"4","key":"ref3","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.3748\/wjg.v22.i4.1650","article-title":"Hepatitis C in non-hepatic solid organ transplant candidates and recipients: A new horizon","volume":"22","author":"Belga","year":"2016","unstructured":"4.\tBelga S, Doucette KE. Hepatitis C in non-hepatic solid organ transplant candidates and recipients: A new horizon. World J Gastroenterol. 2016;22(4):1650-1663.","journal-title":"World J Gastroenterol"},{"issue":"12","key":"ref4","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1111\/tri.12870","article-title":"Use of direct-acting agents for hepatitis C virus-positive kidney transplant candidates and kidney transplant recipients","volume":"29","author":"Rostaing","year":"2016","unstructured":"5.\tRostaing L, Alric L, Kamar N. Use of direct-acting agents for hepatitis C virus-positive kidney transplant candidates and kidney transplant recipients. Transpl Int. 2016;29(12):1257-1265.","journal-title":"Transpl Int"},{"issue":"4","key":"ref5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1159\/000444470","article-title":"Challenges in special populations: HIV\/HCV coinfection, liver transplantation and patients with end-stage renal disease","volume":"34","author":"Bonacci","year":"2016","unstructured":"6.\tBonacci M, Lens S, Marino Z, Forns X. Challenges in special populations: HIV\/HCV coinfection, liver transplantation and patients with end-stage renal disease. Dig Dis. 2016;34(4):317-326.","journal-title":"Dig Dis"},{"issue":"1","key":"ref6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jhep.2016.02.044","article-title":"Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C","volume":"65","author":"Desnoyer","year":"2016","unstructured":"7.\tDesnoyer A, Pospai D, Le MP, et al. Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C. J Hepatol. 2016;65(1):40-47.","journal-title":"J Hepatol"},{"issue":"11","key":"ref7","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1111\/ajt.14490","article-title":"Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study","volume":"17","author":"Dharancy","year":"2017","unstructured":"8.\tDharancy S, Coilly A, Fougerou-Leurent C, et al. Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study. Am J Transplant. 2017;17(11):2869-2878.","journal-title":"Am J Transplant"},{"issue":"30","key":"ref8","doi-asserted-by":"publisher","first-page":"e7568","DOI":"10.1097\/MD.0000000000007568","article-title":"Direct-acting antiviral agent efficacy and safety in renal transplant recipients with chronic hepatitis C virus infection: A PRISMA-compliant study.","volume":"96","author":"Chen","year":"2017","unstructured":"9.\tChen K, Lu P, Song R, et al. Direct-acting antiviral agent efficacy and safety in renal transplant recipients with chronic hepatitis C virus infection: A PRISMA-compliant study. Medicine (Baltimore). 2017;96(30):e7568.","journal-title":"Medicine (Baltimore)","ISSN":"https:\/\/id.crossref.org\/issn\/0025-7974","issn-type":"print"},{"key":"ref9","unstructured":"2. MediCalc Glomerular filtration rate. MDRD-6. http:\/\/www.scymed.com\/en\/smnxps\/psdgq277.htm"},{"key":"ref10","unstructured":"3. Word Health Organization Web site. WHO Toxicity Grading Scale for Determining the Severity of Adverse Events. 2006; http:\/\/www.icssc.org\/documents\/resources\/aemanual2003appendicesfebruary_06_2003%20final.pdf."},{"issue":"5","key":"ref11","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.kint.2016.01.011","article-title":"New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant","volume":"89","author":"Fabrizi","year":"2016","unstructured":"12.\tFabrizi F, Martin P, Messa P. New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant. Kidney Int. 2016;89(5):988-994.","journal-title":"Kidney Int"},{"issue":"9","key":"ref12","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/tri.12799","article-title":"DAA-based antiviral treatment of patients with chronic hepatitis C in the pre- and postkidney transplantation setting","volume":"29","author":"Beinhardt","year":"2016","unstructured":"13.\tBeinhardt S, Al Zoairy R, Ferenci P, et al. DAA-based antiviral treatment of patients with chronic hepatitis C in the pre- and postkidney transplantation setting. Transpl Int. 2016;29(9):999-1007.","journal-title":"Transpl Int"},{"issue":"7","key":"ref13","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1053\/j.gastro.2016.02.078","article-title":"Efficacy of direct-acting antiviral combination for patients with hepatitis C Virus Genotype 1 infection and severe renal impairment or end-stage renal disease","volume":"150","author":"Pockros","year":"2016","unstructured":"14.\tPockros PJ, Reddy KR, Mantry PS, et al. Efficacy of direct-acting antiviral combination for patients with hepatitis C Virus Genotype 1 infection and severe renal impairment or end-stage renal disease. Gastroenterology. 2016;150(7):1590-1598.","journal-title":"Gastroenterology"},{"issue":"12","key":"ref14","doi-asserted-by":"publisher","first-page":"924","DOI":"10.3109\/23744235.2015.1078908","article-title":"Use of sofosbuvir-based direct-acting antiviral therapy for hepatitis C viral infection in patients with severe renal insufficiency","volume":"47","author":"Hundemer","year":"2015","unstructured":"15.\tHundemer GL, Sise ME, Wisocky J, et al. Use of sofosbuvir-based direct-acting antiviral therapy for hepatitis C viral infection in patients with severe renal insufficiency. Infect Dis (Lond). 2015;47(12):924-929.","journal-title":"Infect Dis (Lond)"},{"issue":"7","key":"ref15","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/liv.13336","article-title":"Efficacy and safety of direct-acting antivirals-based antiviral therapies for hepatitis C virus patients with stage 4-5 chronic kidney disease: a meta-analysis","volume":"37","author":"Li","year":"2017","unstructured":"16.\tLi T, Qu Y, Guo Y, Wang Y, Wang L. Efficacy and safety of direct-acting antivirals-based antiviral therapies for hepatitis C virus patients with stage 4-5 chronic kidney disease: a meta-analysis. Liver Int. 2017;37(7):974-981.","journal-title":"Liver Int"},{"issue":"10","key":"ref16","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2215\/CJN.02510317","article-title":"Effect of sofosbuvir-based hepatitis C virus therapy on kidney function in patients with CKD","volume":"12","author":"Sise","year":"2017","unstructured":"17.\tSise ME, Backman E, Ortiz GA, et al. Effect of sofosbuvir-based hepatitis C virus therapy on kidney function in patients with CKD. Clin J Am Soc Nephrol. 2017;12(10):1615-1623.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"ref17","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1016\/j.transproceed.2016.07.034","article-title":"Hepatitis C treatment with direct-acting antivirals in kidney transplant: preliminary results from a multicenter study","volume":"48","author":"Gentil","year":"2016","unstructured":"18.\tGentil MA, Gonzalez-Corvillo C, Perello M, et al. Hepatitis C treatment with direct-acting antivirals in kidney transplant: preliminary results from a multicenter study. Transplant Proc. 2016;48(9):2944-2946.","journal-title":"Transplant Proc"},{"issue":"6","key":"ref18","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/liv.13102","article-title":"Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function","volume":"36","author":"Saxena","year":"2016","unstructured":"19.\tSaxena V, Koraishy FM, Sise ME, et al. Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function. Liver Int. 2016;36(6):807-816.","journal-title":"Liver Int"},{"issue":"5","key":"ref19","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1111\/ajt.13518","article-title":"Efficacy and safety of sofosbuvir-based antiviral therapy to treat hepatitis C virus infection after kidney transplantation","volume":"16","author":"Kamar","year":"2016","unstructured":"20.\tKamar N, Marion O, Rostaing L, et al. Efficacy and safety of sofosbuvir-based antiviral therapy to treat hepatitis C virus infection after kidney transplantation. Am J Transplant. 2016;16(5):1474-1479.","journal-title":"Am J Transplant"},{"issue":"2","key":"ref20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.7326\/M16-1205","article-title":"Treatment With ledipasvir-sofosbuvir for 12 or 24 weeks in kidney transplant recipients with chronic hepatitis C Virus genotype 1 or 4 infection: a randomized trial","volume":"166","author":"Colombo","year":"2017","unstructured":"21.\tColombo M, Aghemo A, Liu H, et al. Treatment With ledipasvir-sofosbuvir for 12 or 24 weeks in kidney transplant recipients with chronic hepatitis C Virus genotype 1 or 4 infection: a randomized trial. Ann Intern Med. 2017; 166(2):109-117.","journal-title":"Ann Intern Med"},{"issue":"4","key":"ref21","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.jhep.2016.12.020","article-title":"Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C","volume":"66","author":"Fernandez","year":"2017","unstructured":"22.\tFernandez I, Munoz-Gomez R, Pascasio JM, et al. Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C. J Hepatol. 2017;66(4):718-723.","journal-title":"J Hepatol"},{"issue":"2","key":"ref22","doi-asserted-by":"publisher","first-page":"e0172159","DOI":"10.1371\/journal.pone.0172159","article-title":"Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study.","volume":"12","author":"Kondili","year":"2017","unstructured":"23.\tKondili LA, Gaeta GB, Ieluzzi D, et al. Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study. PLoS One. 2017;12(2):e0172159.","journal-title":"PLoS One","ISSN":"https:\/\/id.crossref.org\/issn\/1932-6203","issn-type":"print"},{"issue":"2","key":"ref23","doi-asserted-by":"publisher","first-page":"S784","DOI":"10.1016\/S0168-8278(16)01530-0","article-title":"Renal function decline is frequent in patients undergoing hepatitis C treatment post kidney transplant.","volume":"64","author":"Bhamidimarri","year":"2016","unstructured":"24.\tBhamidimarri KR, Martin P, Levy C, Roth D. Renal function decline is frequent in patients undergoing hepatitis C treatment post kidney transplant. J Hepatol. 2016;64(2):S784-S785.","journal-title":"J Hepatol","ISSN":"https:\/\/id.crossref.org\/issn\/0168-8278","issn-type":"print"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T07:34:13Z","timestamp":1549438453000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/forms\/ectrxcontentshow.php?doi_id=10.6002\/ect.2018.0095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2018.0095","relation":{},"ISSN":["1304-0855"],"issn-type":[{"value":"1304-0855","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}